• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594882)   Today's Articles (4729)   Subscriber (49328)
For: Grillo-López AJ. The ODAC Chronicles: Part 3. The FDA’s philosophy and process for cancer drug evaluation and approval. Expert Rev Anticancer Ther 2005;5:1-5. [PMID: 15757431 DOI: 10.1586/14737140.5.1.1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Number Cited by Other Article(s)
1
Grillo-López AJ. The USA’s healthcare debacle: the role of the US FDA. Expert Rev Anticancer Ther 2010;10:607-8. [DOI: 10.1586/era.10.51] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
2
Grillo-López AJ. The ODAC Chronicles: part 7. Tale of two goals. Expert Rev Anticancer Ther 2005;5:939-41. [PMID: 16336083 DOI: 10.1586/14737140.5.6.939] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
3
Grillo-López AJ. The ODAC Chronicles: part 6b. ODAC's structure and function. Expert Rev Anticancer Ther 2005;5:753-6. [PMID: 16221044 DOI: 10.1586/14737140.5.5.753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA